Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer.
Zhu Z, Song Z, Jiao W, Mei W, Xu C, Huang Q, An C, Shi J, Wang W, Yu G, Sun P, Zhang Y, Shen J, Song Y, Qian J, Yao W, Yang H; written on behalf of AME Lung Cancer Collaborative Group. Zhu Z, et al. Transl Lung Cancer Res. 2021 Feb;10(2):815-825. doi: 10.21037/tlcr-20-1024. Transl Lung Cancer Res. 2021. PMID: 33718024 Free PMC article.
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.
Xu Y, Wan B, Chen X, Zhan P, Zhao Y, Zhang T, Liu H, Afzal MZ, Dermime S, Hochwald SN, Hofman P, Borghaei H, Lin D, Lv T, Song Y; written on behalf of AME Lung Cancer Collaborative Group. Xu Y, et al. Transl Lung Cancer Res. 2019 Aug;8(4):413-428. doi: 10.21037/tlcr.2019.08.09. Transl Lung Cancer Res. 2019. PMID: 31555516 Free PMC article.
The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients.
Li H, Xu Y, Wan B, Song Y, Zhan P, Hu Y, Zhang Q, Zhang F, Liu H, Li T, Sugimura H, Cappuzzo F, Lin D, Lv T; written on behalf of AME Lung Cancer Collaborative Group. Li H, et al. Transl Lung Cancer Res. 2019 Aug;8(4):429-449. doi: 10.21037/tlcr.2019.08.04. Transl Lung Cancer Res. 2019. PMID: 31555517 Free PMC article.
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort.
Song Y, Hu C, Xie Z, Wu L, Zhu Z, Rao C, Liu L, Chen Y, Liang N, Chen J, Hu C, Yang N, Hu J, Zhao W, Tong G, Dong X, Zheng D, Jin M, Chen J, Huang M, He Y, Rosell R, Lippi G, Mino-Kenudson M, Han-Zhang H, Mao X, Zhang L, Liu H, Field JK, Chuai S, Ye J, Han Y, Lu S; Written on behalf of AME Lung Cancer Collaborative Group. Song Y, et al. Transl Lung Cancer Res. 2020 Apr;9(2):269-279. doi: 10.21037/tlcr.2020.03.17. Transl Lung Cancer Res. 2020. PMID: 32420066 Free PMC article.
A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer.
Zhu Z, Mei W, Song Z, Jiao W, Huang Q, Zhu L, An C, Shi J, Wang W, Yu G, Sun P, Zhang Y, Shen J, Song Y, Gilbert S, Ruetzler K, Villamizar NR, Xu C, Qian J, Yao W, Yang H; written on behalf of AME Lung Cancer Collaborative Group. Zhu Z, et al. Transl Lung Cancer Res. 2021 Dec;10(12):4587-4599. doi: 10.21037/tlcr-21-959. Transl Lung Cancer Res. 2021. PMID: 35070763 Free PMC article.